Randomized, Double Blinded, Placebo Controlled, Single Dose Escalation Study of 608 in Healthy Subjects
- Status
- UNKNOWN
- Phase
- PHASE1
Clinical Trials Related to Moderate to Severe Plaque Psoriasis
Related studies linked through entity extraction aliases.
A Study to Evaluate the Efficacy and Safety of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis
- Status
- COMPLETED
- Phase
- PHASE3
An International Multicenter, Randomized, Double-blind, Placebo-Controlled Clinical Study of Efficacy and Safety of Two Dosing Regimens of BCD-085 (JSC BIOCAD, Russia) in Patients With Moderate to Severe Plaque Psoriasis
- Status
- COMPLETED
- Phase
- PHASE3
Analysis of the Pathogenesis of Itch in Response to Apremilast Therapy in Psoriasis Patients
- Status
- WITHDRAWN
- Phase
- PHASE4
A Study of KHK4827 (Brodalumab) in Subjects With Moderate to Severe Psoriasis in Korea
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Provide Real-world Evidence on the Treatment Goal Achievement Rate, Adherence to and Utilization Patterns of Adalimumab in Patients With Moderate to Severe Plaque Psoriasis in Greece
- Status
- COMPLETED
- Phase
- N/A
MSB11022 in Moderate to Severe Chronic Plaque Psoriasis
- Status
- COMPLETED
- Phase
- PHASE3
Investigate Effect of Secukinumab on the PK of Midazolam in Patients With Mod to Sev Plaque Psoriasis
- Status
- COMPLETED
- Phase
- PHASE1
A Phase 2 Clinical Study of KHK4827
- Status
- COMPLETED
- Phase
- PHASE2
P3 Study Brodalumab in Treatment of Moderate to Severe Plaque Psoriasis
- Status
- TERMINATED
- Phase
- PHASE3
An Open-Label, Prospective Study to Assess the Safety and Effectiveness of Adalimumab in Patients With Moderate to Severe Plaque Psoriasis in the Russian Federation
- Status
- COMPLETED
- Phase
- PHASE4
Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
- Status
- COMPLETED
- Phase
- PHASE2
An Observational Study to Evaluate Patient-Reported Experiences of Living With Moderate-to-Severe Plaque Psoriasis
- Status
- COMPLETED
- Phase
- N/A
Effectiveness of Adalimumab in Moderate to Severe Plaque Psoriasis Patients With Distinct Co-morbidities
- Status
- COMPLETED
- Phase
- N/A
Open Label, Single Dose, Non-randomized Study to Assess the Drug to Drug Interaction of Briakinumab on CYP Substrates.
- Status
- WITHDRAWN
- Phase
- PHASE1
Effectiveness of Adalimumab (HUMIRA®) in the Treatment of Scalp and Nail Affection in Patients With Moderate to Severe Plaque Psoriasis in Routine Clinical Practice
- Status
- COMPLETED
- Phase
- N/A
Documentation of Humira in Psoriasis Patients in Routine Clinical Practice
- Status
- COMPLETED
- Phase
- N/A
Study Comparing the Efficacy and Safety of ABT-874 to Etanercept and Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis
- Status
- COMPLETED
- Phase
- PHASE3
Open Label Continuation Study in Moderate to Severe Psoriasis
- Status
- COMPLETED
- Phase
- PHASE3